Ray Dalio Quidel Ortho Corp Transaction History

Bridgewater Associates, LP

$21.1 Billion
Q4 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Quidel Ortho Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 6,257 shares of QDEL stock, worth $242,020. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,257

Previous 21,948 71.49%

Holding current value

$242,020

Previous $1 Million 72.2%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$36.18 - $44.84 $567,700 - $703,584	-15,691 Reduced 71.49%	6,257 $278,000
Q3 2024 Nov 13, 2024	SELL	$29.96 - $46.4 $544,043 - $842,577	-18,159 Reduced 45.28%	21,948 $1 Million
Q2 2024 Aug 14, 2024	SELL	$32.9 - $47.0 $179,502 - $256,432	-5,456 Reduced 11.97%	40,107 $1.33 Million
Q1 2024 May 14, 2024	SELL	$41.76 - $74.73 $324,767 - $581,175	-7,777 Reduced 14.58%	45,563 $2.18 Million
Q4 2023 Feb 14, 2024	SELL	$58.16 - $75.44 $327,731 - $425,104	-5,635 Reduced 9.55%	53,340 $3.93 Million
Q3 2023 Nov 13, 2023	BUY	$70.9 - $88.63 $333,088 - $416,383	4,698 Added 8.66%	58,975 $4.31 Million
Q2 2023 Aug 11, 2023	SELL	$81.09 - $94.16 $467,321 - $542,644	-5,763 Reduced 9.6%	54,277 $4.5 Million
Q1 2023 May 12, 2023	SELL	$82.98 - $91.46 $207,201 - $228,375	-2,497 Reduced 3.99%	60,040 $5.35 Million
Q4 2022 Feb 13, 2023	SELL	$66.93 - $97.5 $1.11 Million - $1.62 Million	-16,577 Reduced 20.95%	62,537 $5.36 Million
Q3 2022 Nov 10, 2022	SELL	$69.86 - $107.63 $932,072 - $1.44 Million	-13,342 Reduced 14.43%	79,114 $5.66 Million
Q2 2022 Aug 11, 2022	BUY	$89.06 - $117.64 $8.23 Million - $10.9 Million	92,456 New	92,456 $8.99 Million

Others Institutions Holding QDEL

# of Institutions

303

Shares Held

68.3M

Call Options Held

315K

Put Options Held

189K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.59B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account